{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:50:52Z","timestamp":1790700652771,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.expneurol.2005.05.009","type":"journal-article","created":{"date-parts":[[2005,7,13]],"date-time":"2005-07-13T22:12:55Z","timestamp":1121292775000},"page":"322-329","source":"Crossref","is-referenced-by-count":22,"title":["Intra-nigral MPTP lesion in rats: Behavioral and autoradiography studies"],"prefix":"10.1016","volume":"195","author":[{"given":"Juliana C.","family":"Perry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora C.","family":"Hip\u00f3lide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Tufik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan D.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio","family":"Da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andreatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida B.F.","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2005.05.009_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0006-8993(93)91069-5","article-title":"Change in brain dopamine receptor in MPTP parkinsionian monkeys following L-Dopa treatment","volume":"625","author":"Alexander","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.05.009_bib2","series-title":"Ethical and Practical Principles of the Use of Laboratory Animals","first-page":"45","article-title":"Experimental procedure","author":"Andersen","year":"2004"},{"key":"10.1016\/j.expneurol.2005.05.009_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-0987(00)00170-6","article-title":"Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse","volume":"12","author":"Araki","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.expneurol.2005.05.009_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/377424a0","article-title":"Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors","volume":"377","author":"Baik","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2005.05.009_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.expneurol.2004.11.006","article-title":"Lesion of the substantia nigra pars compacta impairs delayed alternation in a Y-maze in rats","volume":"192","author":"Braga","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib6","series-title":"Experiments in Personality","article-title":"Experiments in psychogenetics","author":"Broadhurst","year":"1960"},{"key":"10.1016\/j.expneurol.2005.05.009_bib7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.410310209","article-title":"Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography","volume":"31","author":"Brooks","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0773.1989.tb01150.x","article-title":"Dopamine D1 and D2 receptors visualized in MPTP treated C57 mice by in vitro autoradiography: lack of evidence of receptor modifications in parkinsonian mice","volume":"65","author":"Camps","year":"1989","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0006-291X(84)91293-2","article-title":"Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase","volume":"120","author":"Chiba","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2005.05.009_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0006-8993(89)90031-0","article-title":"Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology","volume":"483","author":"Cort\u00e9s","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.05.009_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0166-4328(01)00211-X","article-title":"Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia","volume":"124","author":"Da Cunha","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2005.05.009_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1020736131907","article-title":"The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities","volume":"22","author":"Da Cunha","year":"2002","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1074-7427(03)00008-X","article-title":"Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system","volume":"79","author":"Da Cunha","year":"2003","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.expneurol.2005.05.009_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(99)00573-7","article-title":"Spatial learning deficit in dopamine D1 receptor knockout mice","volume":"383","author":"El-Ghundi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib15","series-title":"Merritt's Neurology","first-page":"679","article-title":"Parkinsonism","author":"Fahn","year":"2000"},{"key":"10.1016\/j.expneurol.2005.05.009_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0091-3057(90)90354-K","article-title":"Is experimental catalepsy properly measured?","volume":"35","author":"Ferr\u00e9","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2005.05.009_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02260967","article-title":"MPTP-induced behavioural and biochemical deficits: a parametric analysis","volume":"7","author":"Fredriksson","year":"1994","journal-title":"J. Neural Transm., Parkinson's Dis. Dement. Sect."},{"key":"10.1016\/j.expneurol.2005.05.009_bib18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1471-4159.1997.69031322.x","article-title":"Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter","volume":"69","author":"Gainetdinov","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2005.05.009_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","article-title":"Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man","volume":"103","author":"Gerlach","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2005.05.009_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/neur.1996.0041","article-title":"The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse","volume":"5","author":"German","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.expneurol.2005.05.009_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S1461145701002619","article-title":"l-Dopa restores striatal dopamine level but fails to reverse MPTP-induced memory deficits in rats","volume":"4","author":"Gevaerd","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.expneurol.2005.05.009_bib22","first-page":"1008","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Part 2. central administration of 1-methyl-4-phenylpyridinium","volume":"270","author":"Giovanni","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2005.05.009_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0006-8993(93)90694-I","article-title":"Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism","volume":"602","author":"Graham","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.05.009_bib25","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1016\/0197-0186(92)90256-Q","article-title":"The MPTP-treated mouse as a model of parkinsonism: how good is it?","volume":"20","author":"Heikkila","year":"1992","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2005.05.009_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2005.05.009_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0163-7258(94)90041-8","article-title":"Dopamine receptors: molecular biology, biochemistry and behavioural aspects","volume":"64","author":"Jackson","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2005.05.009_bib28","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite 1-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.expneurol.2005.05.009_bib29","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1523\/JNEUROSCI.18-09-03470.1998","article-title":"Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations","volume":"18","author":"Kelly","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2005.05.009_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(98)00160-0","article-title":"Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats","volume":"102","author":"Lindner","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2005.05.009_bib31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0361-9230(92)90035-V","article-title":"Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"28","author":"Mitra","year":"1992","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2005.05.009_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0361-9230(02)00754-2","article-title":"Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions","volume":"58","author":"Miyoshi","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2005.05.009_bib33","first-page":"1073","article-title":"Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine","volume":"50","author":"Morissette","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0306-4522(95)00511-0","article-title":"Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster","volume":"71","author":"Nobrega","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2005.05.009_bib35","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.expneurol.2005.05.009_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2003.11.029","article-title":"Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra in rats","volume":"484","author":"Perry","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0022-510X(88)90106-2","article-title":"D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy","volume":"86","author":"Pierot","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2005.05.009_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease","volume":"991","author":"Przedborski","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2005.05.009_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0014-2999(85)90101-3","article-title":"Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects","volume":"113","author":"Raisman","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0006-291X(86)80483-1","article-title":"Uptake of the neurotoxin MPP+ by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+","volume":"134","author":"Ramsay","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2005.05.009_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0006-8993(85)91441-6","article-title":"Dopamine D1 receptors in the parkinsonian brain","volume":"359","author":"Rinne","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.05.009_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1098-2396(199701)25:1<73::AID-SYN9>3.0.CO;2-C","article-title":"Localized changes in the GABA-gated chloride channel in rat brain after long-term haloperidol: relation to vacuous chewing movements","volume":"25","author":"Sasaki","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2005.05.009_bib43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/brain\/116.4.853","article-title":"Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naive parkinsonism. Diagnostic implications of the D2 receptor status","volume":"116","author":"Sawle","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2005.05.009_bib44","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2005.05.009_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(86)90444-9","article-title":"The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice","volume":"129","author":"Sonsalla","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-8993(87)90986-3","article-title":"Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL\/6 mice. Comparison with three other strains of mice","volume":"405","author":"Sundstr\u00f6m","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2005.05.009_bib47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0361-9230(97)00452-8","article-title":"Cognitive changes in mice following moderate MPTP exposure","volume":"45","author":"Tanila","year":"1998","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2005.05.009_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2005.05.009_bib51","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/376572a0","article-title":"Modulation of memory fields by dopamine D1 receptors in prefrontal cortex","volume":"376","author":"Williams","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2005.05.009_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/nbdi.1997.0157","article-title":"Do compensatory processes underlie the pre-clinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism","volume":"4","author":"Zigmond","year":"1997","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2005.05.009_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0024-3205(84)90147-4","article-title":"Parkinson's disease: studies with an animal model","volume":"35","author":"Zigmond","year":"1984","journal-title":"Life Sci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605001810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488605001810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T10:46:23Z","timestamp":1551869183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488605001810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0014488605001810"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2005.05.009","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}